Molecular cloning of a novel α2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids

Tetsuya Okajima, Satoshi Fukumoto, Hiroshi Miyazaki, Hideharu Ishida, Makoto Kiso, Keiko Furukawa, Takeshi Urano, Koichi Furukawa

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

A novel member of the human CMP-NeuAc:β-galactoside α2,3- sialyltransferase (ST) subfamily, designated ST3Gal VI, was identified based on BLAST analysis of expressed sequence tags, and a cDNA clone was isolated from a human melanoma line library. The sequence of ST3Gal VI encoded a type II membrane protein with 2 amino acids of cytoplasmic domain, 32 amino acids of transmembrane region, and a large catalytic domain with 297 amino acids; and showed homology to previously cloned ST3Gal III, ST3Gal IV, and ST3Gal V at 34, 38, and 33%, respectively. Extracts from L cells transfected with ST3Gal VI cDNA in a expression vector and a fusion protein with protein A showed an enzyme activity of α2,3-sialyltransferase toward Galβ1,4GlcNAc structure on glycoproteins and glycolipids. In contrast to ST3Gal III and ST3Gal IV, this enzyme exhibited restricted substrate specificity, i.e. it utilized Galβ1, 4GlcNAc on glycoproteins, and neolactotetraosylceramide and neolactohexaosylceramide, but not lactotetraosylceramide, lactosylceramide, or asialo-GM1. Consequently, these data indicated that this enzyme is involved in the synthesis of sialyl-paragloboside, a precursor of sialyl- Lewis X determinant.

Original languageEnglish
Pages (from-to)11479-11486
Number of pages8
JournalJournal of Biological Chemistry
Volume274
Issue number17
DOIs
Publication statusPublished - Apr 23 1999
Externally publishedYes

Fingerprint

beta-galactoside alpha-2,3-sialyltransferase
Sialyltransferases
Cloning
Glycolipids
Molecular Cloning
Glycoproteins
Amino Acids
Enzymes
Complementary DNA
Cytidine Monophosphate
Galactosides
Expressed Sequence Tags
Staphylococcal Protein A
Enzyme activity
Substrate Specificity
lactosamine
Cell Extracts
Libraries
Melanoma
Catalytic Domain

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Molecular cloning of a novel α2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. / Okajima, Tetsuya; Fukumoto, Satoshi; Miyazaki, Hiroshi; Ishida, Hideharu; Kiso, Makoto; Furukawa, Keiko; Urano, Takeshi; Furukawa, Koichi.

In: Journal of Biological Chemistry, Vol. 274, No. 17, 23.04.1999, p. 11479-11486.

Research output: Contribution to journalArticle

Okajima, Tetsuya ; Fukumoto, Satoshi ; Miyazaki, Hiroshi ; Ishida, Hideharu ; Kiso, Makoto ; Furukawa, Keiko ; Urano, Takeshi ; Furukawa, Koichi. / Molecular cloning of a novel α2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. In: Journal of Biological Chemistry. 1999 ; Vol. 274, No. 17. pp. 11479-11486.
@article{860d64d740e34cea95f9b2bdacd7575a,
title = "Molecular cloning of a novel α2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids",
abstract = "A novel member of the human CMP-NeuAc:β-galactoside α2,3- sialyltransferase (ST) subfamily, designated ST3Gal VI, was identified based on BLAST analysis of expressed sequence tags, and a cDNA clone was isolated from a human melanoma line library. The sequence of ST3Gal VI encoded a type II membrane protein with 2 amino acids of cytoplasmic domain, 32 amino acids of transmembrane region, and a large catalytic domain with 297 amino acids; and showed homology to previously cloned ST3Gal III, ST3Gal IV, and ST3Gal V at 34, 38, and 33{\%}, respectively. Extracts from L cells transfected with ST3Gal VI cDNA in a expression vector and a fusion protein with protein A showed an enzyme activity of α2,3-sialyltransferase toward Galβ1,4GlcNAc structure on glycoproteins and glycolipids. In contrast to ST3Gal III and ST3Gal IV, this enzyme exhibited restricted substrate specificity, i.e. it utilized Galβ1, 4GlcNAc on glycoproteins, and neolactotetraosylceramide and neolactohexaosylceramide, but not lactotetraosylceramide, lactosylceramide, or asialo-GM1. Consequently, these data indicated that this enzyme is involved in the synthesis of sialyl-paragloboside, a precursor of sialyl- Lewis X determinant.",
author = "Tetsuya Okajima and Satoshi Fukumoto and Hiroshi Miyazaki and Hideharu Ishida and Makoto Kiso and Keiko Furukawa and Takeshi Urano and Koichi Furukawa",
year = "1999",
month = "4",
day = "23",
doi = "10.1074/jbc.274.17.11479",
language = "English",
volume = "274",
pages = "11479--11486",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "17",

}

TY - JOUR

T1 - Molecular cloning of a novel α2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids

AU - Okajima, Tetsuya

AU - Fukumoto, Satoshi

AU - Miyazaki, Hiroshi

AU - Ishida, Hideharu

AU - Kiso, Makoto

AU - Furukawa, Keiko

AU - Urano, Takeshi

AU - Furukawa, Koichi

PY - 1999/4/23

Y1 - 1999/4/23

N2 - A novel member of the human CMP-NeuAc:β-galactoside α2,3- sialyltransferase (ST) subfamily, designated ST3Gal VI, was identified based on BLAST analysis of expressed sequence tags, and a cDNA clone was isolated from a human melanoma line library. The sequence of ST3Gal VI encoded a type II membrane protein with 2 amino acids of cytoplasmic domain, 32 amino acids of transmembrane region, and a large catalytic domain with 297 amino acids; and showed homology to previously cloned ST3Gal III, ST3Gal IV, and ST3Gal V at 34, 38, and 33%, respectively. Extracts from L cells transfected with ST3Gal VI cDNA in a expression vector and a fusion protein with protein A showed an enzyme activity of α2,3-sialyltransferase toward Galβ1,4GlcNAc structure on glycoproteins and glycolipids. In contrast to ST3Gal III and ST3Gal IV, this enzyme exhibited restricted substrate specificity, i.e. it utilized Galβ1, 4GlcNAc on glycoproteins, and neolactotetraosylceramide and neolactohexaosylceramide, but not lactotetraosylceramide, lactosylceramide, or asialo-GM1. Consequently, these data indicated that this enzyme is involved in the synthesis of sialyl-paragloboside, a precursor of sialyl- Lewis X determinant.

AB - A novel member of the human CMP-NeuAc:β-galactoside α2,3- sialyltransferase (ST) subfamily, designated ST3Gal VI, was identified based on BLAST analysis of expressed sequence tags, and a cDNA clone was isolated from a human melanoma line library. The sequence of ST3Gal VI encoded a type II membrane protein with 2 amino acids of cytoplasmic domain, 32 amino acids of transmembrane region, and a large catalytic domain with 297 amino acids; and showed homology to previously cloned ST3Gal III, ST3Gal IV, and ST3Gal V at 34, 38, and 33%, respectively. Extracts from L cells transfected with ST3Gal VI cDNA in a expression vector and a fusion protein with protein A showed an enzyme activity of α2,3-sialyltransferase toward Galβ1,4GlcNAc structure on glycoproteins and glycolipids. In contrast to ST3Gal III and ST3Gal IV, this enzyme exhibited restricted substrate specificity, i.e. it utilized Galβ1, 4GlcNAc on glycoproteins, and neolactotetraosylceramide and neolactohexaosylceramide, but not lactotetraosylceramide, lactosylceramide, or asialo-GM1. Consequently, these data indicated that this enzyme is involved in the synthesis of sialyl-paragloboside, a precursor of sialyl- Lewis X determinant.

UR - http://www.scopus.com/inward/record.url?scp=0033597198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033597198&partnerID=8YFLogxK

U2 - 10.1074/jbc.274.17.11479

DO - 10.1074/jbc.274.17.11479

M3 - Article

C2 - 10206952

AN - SCOPUS:0033597198

VL - 274

SP - 11479

EP - 11486

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 17

ER -